Our top pick for
CURO Group Holdings Corp is a credit services business based in the US. CURO Group shares (CURO) are listed on the NYSE and all prices are listed in US Dollars.
|52-week range||USD$3.3441 - USD$17.5371|
|50-day moving average||USD$15.1542|
|200-day moving average||USD$10.2433|
|Wall St. target price||USD$24.75|
|Dividend yield||USD$0.22 (1.45%)|
|Earnings per share (TTM)||USD$1.799|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing CURO Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CURO Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CURO Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, CURO Group shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CURO Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$169.2 million.
The EBITDA is a measure of a CURO Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$847.4 million|
|Operating margin TTM||17.87%|
|Gross profit TTM||USD$641.7 million|
|Return on assets TTM||8.36%|
|Return on equity TTM||81.62%|
|Market capitalisation||USD$601 million|
TTM: trailing 12 months
There are currently 1.0 million CURO Group shares held short by investors – that's known as CURO Group's "short interest". This figure is 44.8% up from 691,470 last month.
There are a few different ways that this level of interest in shorting CURO Group shares can be evaluated.
CURO Group's "short interest ratio" (SIR) is the quantity of CURO Group shares currently shorted divided by the average quantity of CURO Group shares traded daily (recently around 541121.62162162). CURO Group's SIR currently stands at 1.85. In other words for every 100,000 CURO Group shares traded daily on the market, roughly 1850 shares are currently held short.
However CURO Group's short interest can also be evaluated against the total number of CURO Group shares, or, against the total number of tradable CURO Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CURO Group's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 CURO Group shares in existence, roughly 20 shares are currently held short) or 0.0488% of the tradable shares (for every 100,000 tradable CURO Group shares, roughly 49 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CURO Group.
Find out more about how you can short CURO Group stock.
Dividend payout ratio: 12.43% of net profits
Recently CURO Group has paid out, on average, around 12.43% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.45% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CURO Group shareholders could enjoy a 1.45% return on their shares, in the form of dividend payments. In CURO Group's case, that would currently equate to about $0.22 per share.
While CURO Group's payout ratio might seem low, this can signify that CURO Group is investing more in its future growth.
CURO Group's most recent dividend payout was on 2 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 February 2021 (the "ex-dividend date").
Over the last 12 months, CURO Group's shares have ranged in value from as little as $3.3441 up to $17.5371. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CURO Group's is 3.1237. This would suggest that CURO Group's shares are significantly more volatile than the average for this exchange and represent a higher risk.
CURO Group Holdings Corp., a diversified consumer finance company, provides consumer finance to a range of underbanked consumers in the United States and Canada. The company offers unsecured installment loans, secured installment loans, open-end loans, and single-pay loans, as well as ancillary financial products, including check cashing, proprietary reloadable prepaid debit cards, demand deposit accounts, credit protection insurance, retail installment sales, and money transfer services. It also provides loans through online. The company was formerly known as Speedy Group Holdings Corp. and changed its name to CURO Group Holdings Corp. in May 2016. CURO Group Holdings Corp. was founded in 1997 and is headquartered in Wichita, Kansas.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.